Market positioning Targeting strategic collaborations with CNS-focused biopharma players and healthcare conferences, leveraging Minerva’s established presence in neuroscience research and its advisory board to differentiate in investor and KOL engagement services.

Investor relations Opportunity to offer tailored investor communications and marketing flows to life sciences companies, given Minerva’s active conference participation, public updates, and Scientific Advisory Board formation which signals ongoing fundraising and stakeholder engagement needs.

Clinical data leverage Capitalize on Minerva’s Phase 3 program for roluperidone by proposing data-driven marketing newsletters and audience segmentation that translate complex trial milestones into accessible investor and clinician education content.

Digital infrastructure Position Minerva’s current tech stack (Docker, Kubernetes, Google Ads, Squarespace) as a baseline asset to offer performance marketing optimization, analytics services, and scalable content delivery for health care campaigns.

Strategic partnerships Explore alliances with CROs, research institutes, and KOL networks that align with Minerva’s scientific advisory board focus to accelerate go-to-market activities and broaden clinical trial visibility.